Sodium doping and 3D honeycomb nanoarchitecture: Key features of covalent triazine-based frameworks (CTF) organocatalyst for enhanced solar-driven advanced oxidation processes
Tao Zeng , Shuqi Li , Yi Shen , Haiyan Zhang , Hongru Feng , Xiaole Zhang , Lingxiangyu Li , Zongwei Cai , Shuang Song
{"title":"Sodium doping and 3D honeycomb nanoarchitecture: Key features of covalent triazine-based frameworks (CTF) organocatalyst for enhanced solar-driven advanced oxidation processes","authors":"Tao Zeng , Shuqi Li , Yi Shen , Haiyan Zhang , Hongru Feng , Xiaole Zhang , Lingxiangyu Li , Zongwei Cai , Shuang Song","doi":"10.1016/j.apcatb.2019.117915","DOIUrl":null,"url":null,"abstract":"<div><p><span>Herein, we designed a novel sodium-doped covalent triazine-based framework with a 3D honeycomb nanoarchitecture (H-CTF-Na) as visible-light-responsive organocatalyst to efficiently drive advanced oxidation processes (AOPs). Experimental and theoretical findings reveal that Na doping narrows the band gap by elevating the band edges and the 3D hierarchical nanocellular morphology improves light harvesting and electron transfer. With these merits, H-CTF-Na showed a photoactivity enhancement of 4.9–6.0-fold for the degradation of carbamazepine (CBZ) compared to those of pristine CTFs and g-C</span><sub>3</sub>N<sub>4</sub> through peroxymonosulfate (PMS) activation under visible-light irradiation. The quenching and EPR results indicate that a synergistic effect between photooxidation (<em>h<sup>+</sup></em>) and PMS activation (<sup>•</sup>OH and SO<sub>4</sub><sup>•−</sup>) derived from the vigorous capture of photogenerated e<sup>−</sup><span> by PMS is responsible for the marked efficacy of H-CTF-Na/vis/PMS system. Moreover, this system exhibited excellent versatility in degrading other organics (such as various phenols and dyes) and good reusability in terms of five high-efficiency recycled uses.</span></p></div>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2019-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.apcatb.2019.117915","citationCount":"34","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Medicinal Chemistry Letters","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0926337319306617","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 34
Abstract
Herein, we designed a novel sodium-doped covalent triazine-based framework with a 3D honeycomb nanoarchitecture (H-CTF-Na) as visible-light-responsive organocatalyst to efficiently drive advanced oxidation processes (AOPs). Experimental and theoretical findings reveal that Na doping narrows the band gap by elevating the band edges and the 3D hierarchical nanocellular morphology improves light harvesting and electron transfer. With these merits, H-CTF-Na showed a photoactivity enhancement of 4.9–6.0-fold for the degradation of carbamazepine (CBZ) compared to those of pristine CTFs and g-C3N4 through peroxymonosulfate (PMS) activation under visible-light irradiation. The quenching and EPR results indicate that a synergistic effect between photooxidation (h+) and PMS activation (•OH and SO4•−) derived from the vigorous capture of photogenerated e− by PMS is responsible for the marked efficacy of H-CTF-Na/vis/PMS system. Moreover, this system exhibited excellent versatility in degrading other organics (such as various phenols and dyes) and good reusability in terms of five high-efficiency recycled uses.
期刊介绍:
ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to:
Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics)
Biological characterization of new molecular entities in the context of drug discovery
Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc.
Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry
Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources
Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response
Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic
Mechanistic drug metabolism and regulation of metabolic enzyme gene expression
Chemistry patents relevant to the medicinal chemistry field.